Defence Studies is a multifaceted interdisciplinary field that examines the complexities of military conflict and security policy, along with the technological and economic dimensions that underpin ...
The FDA is expected to decide on treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I.
On-track progress for the New Drug Application (NDA) for paltusotine, with a PDUFA target action date set for September 25, 2025, indicating strong engagement with the FDA. Marketing authorization ...
CEO Rick Stewart stated that "Achieve is on track to submit the NDA for cytisinicline next month." He emphasized that "all internal resources are now focused on a successful NDA submission, acceptance ...
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has ...
Singh maintained guidance that "we'll see top line results released before the end of this calendar quarter, so by the end of this calendar year" for PALISADE-3. Singh projected that top line results ...
Ajey Lele and Gunjan Singh of the Institute for Defence Studies and Analyses offer an Indian perspective on China’s recently released white paper outlining its plans, they say, “to emerge as a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results